ANDA 87154, held by Alpharma US Pharmaceuticals. Prochlorperazine Edisylate.
As of Nov 21, 2026, ANDA 87154 (Prochlorperazine Edisylate), held by Alpharma US Pharmaceuticals, was first approved by FDA on Sep 1, 1982, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 1, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prochlorperazine EdisylateEQ 5MG BASE/5ML · syrup;oral | Prochlorperazine Edisylate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters